Registry evaluating long-term outcomes of Transcatheter aortic valve replacement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry assesses the long-term outcomes of patients undergoing Transcatheter Aortic Valve Replacement (TAVR) in real-world clinical settings. It is connected to the Asian TAVR registry, allowing for a comprehensive follow-up of subjects over a decade. The study aims to gather data that reflects the effectiveness and safety of TAVR procedures outside of controlled clinical trials.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients undergoing TAVR
* Informed consent

Where it's running

• Stanford University
  Stanford, California, United States Recruiting
• Northwestern Memorial Hospital
  Chicago, Illinois, United States Recruiting
• Second Affiliated Hospital of Zhejiang University
  Hangzhou, China Recruiting
• Chungnam National University Hospital
  Daejeon, South Korea Recruiting
• Asan Medical Center
  Seoul, South Korea Recruiting
• Bucheon Sejong Hospital
  Bucheon-si, South Korea Active not recruiting

Study contacts

• Principal investigator: Alan Ching Yuen Yeung, MD — Stanford University
• Study coordinator: Duk-woo Park, MD
• Email: dwpark@amc.seoul.kr
• Phone: 82230103995

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Korea VHD Echo Study: Real-World Practice of Aortic, Mitral, and Tricuspid Valves

  This study looks at how valvular heart disease is managed in Korea by reviewing echocardiograms and medical records from multiple centers to see patterns in disease progression and treatment.

  Recruiting at 2 sites Yonsei University · Seoul, Seoul and 1 other locations · NCT07068633

• Investigating multiple and mixed heart valve diseases

  This study looks at how common different types of heart valve diseases are and their features by gathering information from patients around the world who have been diagnosed with these conditions.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris, Île-de-France Region · NCT06235385

• Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation

  This trial tests the Laplace TTVR System to see if it safely and effectively treats adults with severe tricuspid regurgitation.

  Recruiting at 2 sites Laplace Interventional, Inc · Tulsa, Oklahoma and 1 other locations · NCT07687485

• TRIFORMIS RESILIA heart valve real-world results in tricuspid disease

  A real-world, observational study to see how the Edwards TRIFORMIS RESILIA tricuspid heart valve performs in adults needing tricuspid valve replacement.

  Recruiting Edwards Lifesciences · Carmel, Indiana · NCT07684313

• Multimodal Cardiac MRI to See How the Heart Is Working

  This study tests a comprehensive MRI approach to characterize heart structure and tissue in adults with suspected or confirmed cardiovascular disease.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07617844

• Portable electronic stethoscope and machine-learning detection of heart valve disease

  We will test whether a portable electronic stethoscope combined with a machine-learning algorithm can accurately detect valvular heart disease in people with known valve problems and in healthy volunteers.

  Recruiting The University of Hong Kong · Hong Kong, Pok Fu Lam Rd. · NCT07568795

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.